{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:08:03Z","timestamp":1744866483024},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T00:00:00Z","timestamp":1267142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\/Objectives:\u2002<\/jats:bold> There are concerns about the effectiveness of head lice treatments because of increasing resistance and safety. This trial compared the safety and efficacy of a suffocant\u2010based head lice treatment to malathion in children.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The trial used strict entry criteria, standardized treatment and assessment regimens, sibling treatment where appropriate and a primary efficacy end\u2010point defined as the absence of live head lice.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> A total of 216 children were enrolled. One hundred and sixty\u2010nine were per\u2010protocol. The suffocant was significantly more effective than malathion for the intention\u2010to\u2010treat population (53.9% <jats:italic>vs<\/jats:italic> 40.4% louse\u2010free, unadjusted <jats:italic>P<\/jats:italic>\u2003=\u20030.052; adjusted <jats:italic>P<\/jats:italic>\u2003=\u20030.024), as well as for the per\u2010protocol population (57.8% <jats:italic>vs<\/jats:italic> 43.0% louse\u2010free, unadjusted <jats:italic>P<\/jats:italic>\u2003=\u20030.054; adjusted <jats:italic>P<\/jats:italic>\u2003=\u20030.045). Adverse events were limited to itching or stinging and there were no serious or systemic adverse events. Repeat insult patch testing with the suffocant resulted in no adverse reactions. <jats:italic>In vitro<\/jats:italic> tests confirmed that the suffocant is a potent ovicide and pediculicide with 100% mortality of eggs and lice following a 20\u2010min contact time.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The suffocant is shown to be significantly more effective in eliminating head lice than malathion in children, while being associated with a low incidence of mild, transient adverse events.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2010.00622.x","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T12:38:46Z","timestamp":1267187926000},"page":"175-182","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A randomized, assessor\u2010blind, parallel\u2010group, multicentre, phase IV comparative trial of a suffocant compared with malathion in the treatment of head lice in children"],"prefix":"10.1111","volume":"51","author":[{"given":"Kerryn A","family":"Greive","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada H","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya M","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VM Jane","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.01.134"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.3.638"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2002.tb00675.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1994.tb00600.x"},{"key":"e_1_2_6_6_2","first-page":"S269","article-title":"American Academy of Pediatrics guidelines for the prevention and treatment of head lice infestation","volume":"10","author":"Frankowski BL","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992280404300603"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2007.00045"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-199901030-00005"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-003-0881-y"},{"issue":"2","key":"e_1_2_6_11_2","article-title":"Interventions for treating headlice. (Cochrane Review)","author":"Dodd CS","year":"2003","journal-title":"The Cochrane Library Issue"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.2.220"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.091280"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04473.x"},{"key":"e_1_2_6_15_2","first-page":"S277","article-title":"Head lice treatment costs and the impact on managed care","volume":"10","author":"West DP","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"e_1_2_6_16_2","unstructured":"JamesS.A review of the regulation of head lice treatments in Australia. Prepared for the Medicines Evaluation Committee Therapeutic Goods Administration. Oct 2003."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7401.1256"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-115"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001127"},{"key":"e_1_2_6_20_2","first-page":"371","article-title":"Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate\/cyclomethicone solution against head lice","volume":"280","author":"Burgess IF","year":"2008","journal-title":"Pharm. J."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2210-9-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2009.04.0014"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1040"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06620.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pu.14.050193.000355"},{"key":"e_1_2_6_26_2","first-page":"1292","article-title":"Sample size for cluster randomised trials: Effect of coefficient of variation of cluster size and analysis method","volume":"35","author":"Eldridge SM","year":"2006","journal-title":"BMJ"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02258.x"},{"key":"e_1_2_6_28_2","first-page":"287","article-title":"Comparative efficacy of treatments for Pediculosis capitis infestations: update 2000","volume":"137","author":"Meinking TL","year":"2001","journal-title":"Arch. Dermatol."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38497.506481.8F"},{"key":"e_1_2_6_30_2","first-page":"738","article-title":"A randomised, double\u2010blind, comparative efficacy trial of three head lice treatment options: malathion, pyrethrins with piperonyl butoxide and MOOV Head Lice Solution","volume":"20","author":"Greive KA","year":"2007","journal-title":"Aust. Pharmacist"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0033-3506(00)00342-5","article-title":"The methodology and operation of a pilot randomized control trial of the effectiveness of the Bug Busting method against a single application insecticide product for head louse treatment","volume":"114","author":"Bingham P","year":"2000","journal-title":"Public Health"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2010.00622.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2010.00622.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T18:25:43Z","timestamp":1698776743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2010.00622.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1440-0960.2010.00622.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2010.00622.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"2010-08-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}